Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Tiziana Life Sciences

Tracked across 3 events · 18 articles · First seen Apr 01, 2026 · Last active May 28, 2026

Sentiment
48
Attention
6
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 75
Tech
Impact: Tiziana Life Sciences announced positive preclinical data for its lead candidate, intranasal foralumab, showing its potential to treat Long COVID neuroinflammation and cognitive dysfunction. This positive data could significantly boost the company's stock price and future prospects.
Apr 16, 2026 · 6 articles
6 70
Business
Impact: Tiziana Life Sciences exited its minority stake in Tubulis through this sale, representing a strong strategic outcome for its LSP 7 fund and co-investors.
Apr 07, 2026 · 6 articles
2 0
Business
AstronauTx, a biotechnology company focused on treating Alzheimer's Disease and other neurological disorders, announced the appointments of Dr. Michelle Mellion as Chief Medical Officer (CMO) and Deb Gouveia as Vice President, Clinical Operations and Development…
Impact: Tiziana Life Sciences participated in AstronauTx's Series A financing.
May 12, 2026 · 6 articles
NEWSDESK
Track Tiziana Life Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.